Abstract
Colon cancer (CC) is estimated to be the third most common cause of cancer deaths in the United States in 2010 and the incidence is higher among African Americans compared with Caucasians. Chronic intestinal inflammation is a risk factor for CC. Moreover, mediators of chronic inflammation have been implicated in CC development. MBL, a mannose-binding protein, is a critical component of the innate immune system, and it serves as a front-line protection against pathogens. MBL deficiency is common and present in approximately 5% of the population, predisposing individuals to bacterial and fungal infections. A previous resequencing analysis of the 10.0kbp region that includes the MBL2 gene showed a recombination hot-spot in the 3′ end of the gene, dividing MBL2 into two separate haplotype blocks: 5′UTR and 3′UTR haplotypes. In our previous work, we used a case-control study from the greater Baltimore, Maryland area (261 cases; 537 controls) and observed that haplotypes in both regions are associated with CC risk in African Americans, but not in Caucasians. Moreover, we showed that four single nucleotide polymorphisms (SNPs) comprising a 3′UTR region haplotype are individually associated with increased CC risk in African Americans: rs10082466, rs2120132, rs2099902, and rs10450310. In this study, we investigated whether the SNPs in this haplotype block fell within putative microRNA (miRNA) site due to the observed association of 3′UTR-region haplotypes and plasma MBL levels, using publicly available web-tools. We hypothesized that rs10082466 association with CC is driven by hsa-miR-27a binding to the C allele, resulting in decreased plasma MBL2 levels and activity. We tested the interaction of hsa-miR-27a with the 3′UTR region of MBL2 and its modulation by 3′UTR haplotypes in vitro using reporter constructs via luciferase activity. The increased binding affinity for the C allele of rs10082466 was reflected by a significant decrease in normalized luciferase activity, compared with the T allele. We also showed the C allele to be associated with lower plasma MBL2 levels and activity in cases and controls. Moreover, the fold increase of hsa-mir-27a precursor is significantly higher in African Americans compared to Caucasians in colon cancer. Therefore, 3′UTR haplotype association with CC may be driven by hsa-miR-27a binding to the C allele of rs10082466, which results in decreased plasma MBL2 levels and activity. In addition to the supporting evidence linking low levels of circulating MBL2 to increased susceptibility to infection, these results suggest that a genetic variant in MBL2 may increase colon cancer susceptibility in African Americans by creating a miRNA binding site.
Citation Information: Cancer Epidemiol Biomarkers Prev 2011;20(10 Suppl):B60.